inhibition of mek to treat cancer: focus on melanoma
Published 10 years ago • 2.9K plays • Length 6:10Download video MP4
Download video MP3
Similar videos
-
2:02
mek inhibitors for melanoma: new combination approved
-
6:31
how to choose first line therapy in melanoma?
-
0:52
dr. kudchadkar on combining braf and mek inhibitors to treat melanoma
-
6:52
expert report on novel data in (neo)adjuvant treatment of melanoma from asco 2022
-
2:10
combined treatment with braf and mek inhibitors in metastatic melanomas with braf mutations
-
8:34
#esmo21 expert video report on melanoma
-
4:18
braf/mek inhibition as adjuvant treatment in melanoma
-
6:22
braf and mek in melanoma
-
4:07
understanding resistance to combined braf and mek inhibiton in melanoma and the significance of cdk4
-
3:40
aacr 2023 highlights on advances in the treatment of resected high-risk melanoma with jeffrey weber
-
9:24
anti-pd1 monotherapy or combination with ipi after braf/mek inhibitors in braf-mutant melanoma
-
1:34
study of vemurafenib combined with a mek inhibitor
-
4:15
vemurafenib in combination with the mek inhibitor, gdc-0973 in brafv600 mutation pos melanoma
-
1:09
dr. richard carvajal describes mek inhibition in uveal melanoma
-
6:44
case 2: long-term braf/mek data in melanoma
-
3:44
aacr 2023 highlights on advances in the neoadjuvant treatment of resectable nsclc with john heymach
-
1:22
braf mutations and mek inhibitors
-
6:05
duration of dual braf-mek inhibition
-
8:24
management of side effects for braf/mek inhibitors for melanoma